[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Definium Therapeutics Inc (DFTX)

Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Definium Therapeutics Inc ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 USA

www.definiumtx.com Employees: 106 P: 212-220-6633

Sector:

Medical

Description:

Definium Therapeutics, Inc. is developing therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Definium Therapeutics Inc., formerly known as Mind Medicine Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 2,181,392
Enterprise Value, $K 1,964,132
Shares Outstanding, K 99,698
Float, K 97,445
% Float 97.74%
Short Interest, K 9,820
Short Float 9.85%
Days to Cover 5.85
Short Volume Ratio 0.56
% of Insider Shareholders 2.26%
% of Institutional Shareholders 27.91%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -183,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,440 K
EBIT, $ -166,310 K
EBITDA, $ -168,130 K

Growth:

1-Year Return 231.41%
3-Year Return 541.64%
5-Year Return -55.53%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -20.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 02/26/26
Next Earnings Date 05/14/26 [--]
Earnings Per Share ttm -2.08
EPS Growth vs. Prev Qtr 42.31%
EPS Growth vs. Prev Year -9.76%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/29/22

DFTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -82.07%
Return-on-Assets % -58.73%
Profit Margin % 0.00%
Debt/Equity 0.12
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.32
Book Value/Share 3.36
Interest Coverage -32.54
60-Month Beta 2.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.